1[1]Davis S, Aldrich TH, Jones PF, et al. Isolation of angiopoietin-1, a ligand for the Tie2 receptor, by secretion-trap expression cloning[J]. Cell, 1996, 87: 1161-1169.
2[2]Maisonpierre PC, Suri C, Jones PF, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis[J]. Science, 1997, 277: 55-60.
3[3]Valenzuela DM, Griffiths JA, Rojas J, et al. Angiopoietins 3 and 4: Diverging gene counterparts in mice and humans[J]. Proc Natl Acad Sci USA, 1999, 96: 1904-1909.
4[4]Suri c, Jones PF, Patan S, et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis[J]. Cell, 1996, 87: 1171-1180.
5[5]Oh H, Takagi H, Suzuma K, et al. Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells[J]. J Biol Chem, 1999, 274: 15732-15739.
6[6]Cohen B, Barkan D, Levy Y, et al. Leptin induces angiopoietin-2 expression in adipose tissues[J]. J Biol Chem, 2001, 276: 7697-7700.
7[7]Jones N, Master Z, Jones J, et al. Identification of Tek/Tie2 binding partners[J]. J Biol Chem, 1999, 274: 30896-30905.
8[8]Kim I, Kim HG, So JN, et al. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3 -kinase/Akt signal transduction pathway[J]. Circ Res, 2000, 86: 24-29.
9[9]Papapetropoulos A, Fulton D, Mahboubi K, et al. Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/Survivin pathway[J]. J Biol Chem, 2000, 275: 9102-9105.
10[10]Witzenbichler B, Maisonpierre PC, Jones P, et al. Chemotactic properties of angiopoietin-1 and 2, ligands for the endothelial-specific receptor tyrosine kinase Tie2[J]. J Biol Chem, 1998, 273: 18514-18521.
2Helfrich I, Edler L, Sucker A, et al. Angiopoietin-2 levels are associated with disease progression in metastatic malignant melanoma[J]. Clin Cancer Res,2009,15(4):1384-1392.
3Chung YC, Hou YC,Chang CN, et al. Expression and prognostic significance of angiopoietin in colorectal carcinoma [J]. J Surg Oncol, 2006,94 (7): 631-638.
4Birner P, Schindl M,Obermair A, et al. Overexpression of Hypoxia-inducihle Factor 1α is a marker for an unfavorable prognosis in early-stage invasive cervical cancer[J]. Cancer Res, 2000,6(1(17): 4693-4696.
5Weidner N, Carroll PR, Flax J, et al. Tumor angiogenesis correlates with metastasis in invasive prostate careinoma[J]. Am J Pathol, 1993,143(2) : 401-409.
6Mooteri S, Rubin D, Leurgans S, et al. Tumor angiogenesis in primary and metastatic colorectal cancers[J]. Dis Colon Rectum, 1996,39(10): 1073-1080.
7Alexandrakis MG,Passam FH,Sfiridaki A, et al. Elevated serum angiogenin in muhiple myeloma [J]. Hematol J, 2003, 4 (6) :454-455.
8Ahmad SA, Liu W,Jung YD. Differential expression of angiopoietin-1 and angiopoietin-2 in colon caicinoma. A possible mechanism for the initiation of angiogenesis[J]. Cancer, 2001, 92(5): 1138-1143.
9Dallas NA, Samuel S, Xia L, et al. Endoglin(CD105) : a marker of tumor vasculature and potential target for therapy[J]. Clin Cancer Res, 2008,14 (7) : 1931 - 1937.
10Sarraf-Yazdi S, Mi J, Moeller BJ, et al. Inhibition of in vivo tumor angio genesis and growth via systemic delivery of an angiopoietin2-Specific RNA aptamer[J]. J Surg Res, 2008, 146 (1):16-23.
